期刊文献+

原发性鼻腔鼻窦恶性黑色素瘤八例临床分析

Clinical Analysis of Eight Cases with Primary Malignant Melanoma in Nasal Cavity and Paranasal Sinuses
原文传递
导出
摘要 目的:探讨原发性鼻腔、鼻窦恶性黑色素瘤的诊断和治疗方法。方法:对8例该类患者的临床资料进行回顾性分析。结果:病理形态以多种细胞类型和组织形态混合存在为主要特点,无色素型黑色素瘤S-100蛋白均阳性。所有患者均得到手术治疗且切缘阴性。术后加放疗6例,复发3例,复发灶与原发病灶同侧,复发时间在术后1年左右。1年和2年生存率分别为75%和62%。2例生存期超过5年,均系手术加放疗者。结论:S-100蛋白是无色素型黑色素瘤的重要标志物,术后放疗的患者生存期较长,手术切缘阴性并不提示良好的预后。 Purpose: To investigate the methods of both diagnosis and treatment for primary malignant melanoma in nasal cavity andparanasal sinuses. Method: Eight cases were analysed retrospectively. Results: The pathological features were the mixed existance of dif-ferent cellular patterns and morphologies. There was S-100 protein marking for malignant melanoma. All patients underwent surgicalresection and microscopically negative margins,with six receiving postoperative radiotherapy. Three cases recurred at the same side asprimary tumor about one year Iater. The 1 -year and 2-year survival rate in all were 75 % and 62 % respectively. Two cases had sur-vived more than five years who all received postoperative radiotherapy. Conclusion: S-100 protein was an important diagnostic marker formalignant melanoma. Those who received postoperative radiotherapy appeared with prolonged survival. Negative surgical margins werenot predictive of a more favorable outcome.
出处 《浙江肿瘤》 1997年第1期23-24,共2页
关键词 黑色素瘤 鼻肿瘤 鼻窦肿瘤 治疗 预后 Melanoma Nose neoplasms Paranasal sinus neoplasms
  • 相关文献

参考文献3

二级参考文献10

  • 1高天文,国外医学皮肤病学分册,1990年,4卷,195页 被引量:1
  • 2徐思行,中华医学杂志,1978年,58卷,467页 被引量:1
  • 3G. W. Milton,H. M. Shaw Ph.D.. Rare variants of malignant melanoma[J] 1992,World Journal of Surgery(2):173~178 被引量:1
  • 4Seng-Jaw Soong Ph.D.,Helen M. Shaw Ph.D.,Charles M. Balch M.D.,William H. McCarthy M.B.B.S., M.Ed.,Marshall M. Urist M.D.,Jeannette Y. Lee Ph.D.. Predicting survival and recurrence in localized melanoma: A multivariate approach[J] 1992,World Journal of Surgery(2):191~195 被引量:1
  • 5John F. Thompson M.B., B.S., B.Sc. (Med.),Mark P. Gianoutsos M.B., B.S.. Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs[J] 1992,World Journal of Surgery(2):227~233 被引量:1
  • 6Danielle Liénard M.D.,Ferdy J. Lejeune M.D., Ph.D.,Patricia Ewalenko M.D.. In transit metastases of malignant melanoma treated by high dose rTNFα in combination with interferon-γ and melphalan in isolation perfusion[J] 1992,World Journal of Surgery(2):234~240 被引量:1
  • 7Heimen Schraffordt Koops M.D., Ph.D.,Bin B. R. Kroon M.D., Ph.D.,Jan Oldhoff M.D., Ph.D.,Harald J. Hoekstra M.D., Ph.D.. Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of the extremities[J] 1992,World Journal of Surgery(2):241~245 被引量:1
  • 8Peter Hersey. Active immunotherapy with viral lysates of micrometastases following surgical removal of high risk melanoma[J] 1992,World Journal of Surgery(2):251~260 被引量:1
  • 9Isaiah J. Fidler D.V.M.,Ph.D.. Therapy of disseminated melanoma by liposome-activated macrophages[J] 1992,World Journal of Surgery(2):270~276 被引量:1
  • 10Alan S. Coates M.D.. Systemic chemotherapy for malignant melanoma[J] 1992,World Journal of Surgery(2):277~281 被引量:1

共引文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部